{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:03:03Z","timestamp":1791644583589,"version":"4.3.4"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/23260-0"],"award-info":[{"award-number":["2014\/23260-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This pilot clinical study aimed to develop and validate standardized manufacturing and quality control procedures for autologous skeletal muscle-derived (SkM-MSCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs), and to explore the feasibility, safety and preliminary efficacy of periurethral injection of these products in women with stress urinary incontinence (SUI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-six diagnosed with SUI were enrolled and allocated to receive either SkM-MSCs or BM-MSCs. Autologous MSCs were isolated from skeletal muscle or bone marrow biopsies, expanded under Good Manufacturing Practices (GMP), and subjected to rigorous quality control assessments, including identity, genetic stability, viability, potency, and sterility. In this pilot study, ten million MSCs were injected periurethrally under local anesthesia, and participants were followed for 12 months post-treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven SkM-MSCs and nine BM-MSCs final products met all quality criteria and were administered. One participant from the SkM-MSCs lost the follow-up. MSC therapies were well tolerated, with no long-term adverse effects or tumor formation observed. In the SkM-MSCs group, the proportion of women with a positive cough test decreased significantly from 100% to 40% (p\u2009=\u20090.010). In the BM-MSCs group, modest improvements were seen but did not reach statistical significance. Overall, improvements in both pad test outcomes and quality of life measures among participants were observed, though not uniformly significant. The study was discontinued before reaching its intended sample size due to limited efficacy, logistical challenges, and financial constraints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Autologous MSC\u2011based therapy for SUI was feasible and showed an acceptable short\u2011term safety profile in this pilot research setting; however, clinical efficacy remained modest. The manufacturing and quality control methodology is reproducible in specialized cell processing centers, but its application should remain confined to clinical research conducted in compliance with current regulations governing human cell therapy. Future studies with optimized cell products, refined delivery strategies and adequately powered, randomized designs are required before any potential translation to routine clinical practice can be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0342452","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:21:46Z","timestamp":1772216506000},"page":"e0342452","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stem cell therapy for female stress urinary incontinence: Results, limitations and lessons learned from a pilot clinical study"],"prefix":"10.1371","volume":"21","author":[{"given":"Rodrigo C.","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-5320","authenticated-orcid":true,"given":"Maria A. T.","family":"Bortolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Melino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-4297","authenticated-orcid":true,"given":"Juliana A. P.","family":"de Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelen","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise De","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea T.","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Kutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane","family":"Secco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eder","family":"Zucconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1ssia","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Podgaec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-5976","authenticated-orcid":true,"given":"Rebecca S. P.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"1","key":"pone.0342452.ref001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"21","author":"BT Haylen","year":"2010","journal-title":"Int Urogynecol J"},{"key":"pone.0342452.ref002","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1196\/annals.1389.034","article-title":"Functional anatomy of the female pelvic floor","volume":"1101","author":"JA Ashton-Miller","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"pone.0342452.ref003","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/JU.0000000000003435","article-title":"Updates to Surgical Treatment of Female Stress Urinary Incontinence (SUI): AUA\/SUFU Guideline (2023)","volume":"209","author":"KC Kobashi","year":"2023","journal-title":"J Urol"},{"issue":"4","key":"pone.0342452.ref004","first-page":"431","article-title":"Hemopoietic stem cell differentiation","volume":"605","author":"JE Till","year":"1980","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"pone.0342452.ref005","doi-asserted-by":"crossref","DOI":"10.1530\/JME-12-0072","article-title":"Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells","volume":"49","author":"CV Alvarez","year":"2012","journal-title":"J Mol Endocrinol"},{"issue":"6","key":"pone.0342452.ref006","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00192-007-0553-z","article-title":"1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence","volume":"19","author":"LK Carr","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"2","key":"pone.0342452.ref007","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.juro.2012.09.028","article-title":"Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study","volume":"189","author":"LK Carr","year":"2013","journal-title":"J Urol"},{"issue":"2","key":"pone.0342452.ref008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.juro.2014.02.047","article-title":"Autologous muscle derived cells for treatment of stress urinary incontinence in women","volume":"192","author":"KM Peters","year":"2014","journal-title":"J Urol"},{"issue":"7","key":"pone.0342452.ref009","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/iju.13097","article-title":"Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: A prospective study","volume":"23","author":"F Sharifiaghdas","year":"2016","journal-title":"Int J Urol"},{"issue":"12","key":"pone.0342452.ref010","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s11255-018-2005-8","article-title":"A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence","volume":"50","author":"RJ Jankowski","year":"2018","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"pone.0342452.ref011","first-page":"482","article-title":"Autologous Muscle-derived Cell Injection for Treatment of Female Stress Urinary Incontinence: A Single- Arm Clinical Trial with 24-months Follow-Up","volume":"16","author":"F Sharifiaghdas","year":"2019","journal-title":"Urol J"},{"key":"pone.0342452.ref012","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000001974.01","article-title":"A double-blind, randomized, controlled trial comparing safety and efficacy of autologous muscle derived cells for urinary sphincter repair (AMDC-USR) with placebo (PBO) in women with stress urinary incontinence (SUI)","volume":"206","author":"MR Kaufman","year":"2021","journal-title":"J Urol"},{"issue":"3","key":"pone.0342452.ref013","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/kisup.2011.15","article-title":"Biology of stem cells: an overview","volume":"1","author":"PC Chagastelles","year":"2011","journal-title":"Kidney Int Suppl (2011)"},{"issue":"3","key":"pone.0342452.ref014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41585-019-0273-4","article-title":"Regenerative medicine and injection therapies in stress urinary incontinence","volume":"17","author":"CJ Hillary","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"3","key":"pone.0342452.ref015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/2090598X.2020.1750864","article-title":"Stem cell applications in regenerative medicine for stress urinary incontinence: A review of effectiveness based on clinical trials","volume":"18","author":"B Barakat","year":"2020","journal-title":"Arab J Urol"},{"issue":"1","key":"pone.0342452.ref016","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijgo.13769","article-title":"A systematic review of stem cell therapy treatment for women suffering from stress urinary incontinence","volume":"157","author":"H Klapper-Goldstein","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"pone.0342452.ref017","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"M Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"pone.0342452.ref018","doi-asserted-by":"crossref","first-page":"9628536","DOI":"10.1155\/2019\/9628536","article-title":"Challenges and Controversies in Human Mesenchymal Stem Cell Therapy","volume":"2019","author":"B Lukomska","year":"2019","journal-title":"Stem Cells Int"},{"issue":"8","key":"pone.0342452.ref019","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.3390\/ijms22083981","article-title":"Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects","volume":"22","author":"FA Schmid","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"pone.0342452.ref020","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamasurg.2021.0552","article-title":"TREND Reporting Guidelines for Nonrandomized\/Quasi-Experimental Study Designs","volume":"156","author":"AB Haynes","year":"2021","journal-title":"JAMA Surg"},{"issue":"5","key":"pone.0342452.ref021","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/nau.23519","article-title":"ICS Educational Module: Cough stress test in the evaluation of female urinary incontinence: Introducing the ICS-Uniform Cough Stress Test","volume":"37","author":"ML Guralnick","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"pone.0342452.ref022","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/nau.1930100503","article-title":"Objective quantification of stress urinary incontinence: a short, reproducible, provocative pad\u2010test","volume":"10","author":"I Hahn","year":"1991","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"pone.0342452.ref023","doi-asserted-by":"crossref","first-page":"18472","DOI":"10.1038\/s41598-020-75567-8","article-title":"Test-retest reliability of the 20-min pad test with infusion of strong-desired volume in the bladder for female urodynamic stress incontinence","volume":"10","author":"W-Y Wu","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0342452.ref024","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0090-4295(98)00454-3","article-title":"Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL)","volume":"53","author":"DL Patrick","year":"1999","journal-title":"Urology"},{"key":"pone.0342452.ref025","unstructured":"ANVISA \u2013 Resolu\u00e7\u00e3o de Diretoria Colegiada - RDC n\u00ba 508, de 27 de maio de 2021 (Disp\u00f5e sobre as Boas Pr\u00e1ticas em C\u00e9lulas Humanas para Uso Terap\u00eautico e pesquisa cl\u00ednica, e d\u00e1 outras provid\u00eancias). Available in: rdc0508_27_05_2021.pdf"},{"key":"pone.0342452.ref026","article-title":"International Standing Committee on Human Cytogenomic Nomenclature. ISCN 2020: An International System for Human Cytogenomic Nomenclature","year":"2020","journal-title":"Karger"},{"issue":"15","key":"pone.0342452.ref027","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/eurheartj\/eht372","article-title":"Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis","volume":"35","author":"R Delewi","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"pone.0342452.ref028","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ijcard.2014.11.005","article-title":"Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials","volume":"177","author":"B Liu","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"pone.0342452.ref029","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13018-017-0534-y","article-title":"The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review","volume":"12","author":"A Goldberg","year":"2017","journal-title":"J Orthop Surg Res"},{"issue":"4","key":"pone.0342452.ref030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4252\/wjsc.v11.i4.222","article-title":"Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: a concise review","volume":"11","author":"AT Wang","year":"2019","journal-title":"World J Stem Cells"},{"issue":"10","key":"pone.0342452.ref031","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/ijms20102406","article-title":"Genetic stability of mesenchymal stromal cells for regenerative medicine applications: A fundamental biosafety aspect","volume":"20","author":"S Neri","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0342452.ref032","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cpr.12002","article-title":"Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy","volume":"46","author":"R Binato","year":"2013","journal-title":"Cell Prolif"},{"issue":"1","key":"pone.0342452.ref033","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10517-010-1086-x","article-title":"Alterations of cytological and karyological profile of human mesenchymal stem cells during in vitro culturing","volume":"150","author":"AS Grigorian","year":"2010","journal-title":"Bull Exp Biol Med"},{"issue":"5","key":"pone.0342452.ref034","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10517-011-1207-1","article-title":"Study of genetic stability of human bone marrow multipotent mesenchymal stromal cells","volume":"150","author":"VA Nikitina","year":"2011","journal-title":"Bull Exp Biol Med"},{"issue":"2","key":"pone.0342452.ref035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.stem.2011.06.013","article-title":"Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells","volume":"9","author":"U Ben-David","year":"2011","journal-title":"Cell Stem Cell"},{"key":"pone.0342452.ref036","first-page":"1613636","article-title":"Preclinical Evaluation of the Tumorigenic and Immunomodulatory Properties of Human Bone Marrow Mesenchymal Stromal Cell Populations with Clonal Trisomy 5","volume":"2022","author":"MSJ Marodin","year":"2022","journal-title":"Stem Cells Int"},{"issue":"3","key":"pone.0342452.ref037","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/ijms21030708","article-title":"An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem\/Stromal Cells","volume":"21","author":"D-T Chu","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0342452.ref038","first-page":"151","article-title":"Comparative analysis of different surgical procedures for female stress urinary incontinence. Is stem cell implantation the future?","volume":"53","author":"C Surcel","year":"2012","journal-title":"Rom J Morphol Embryol Rev Roum"},{"issue":"4","key":"pone.0342452.ref039","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00192-012-1963-0","article-title":"Ultrasound-guided autologous myoblast injections into the extrinsic urethral sphincter: tissue engineering for the treatment of stress urinary incontinence","volume":"24","author":"M Blaganje","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"9","key":"pone.0342452.ref040","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00192-023-05514-4","article-title":"Transurethral injection of autologous muscle precursor cells for treatment of female stress urinary incontinence: a prospective phase I clinical trial","volume":"34","author":"FA Schmid","year":"2023","journal-title":"Int Urogynecol J"},{"issue":"3","key":"pone.0342452.ref041","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","article-title":"Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies","volume":"129","author":"A Stolzing","year":"2008","journal-title":"Mech Ageing Dev"},{"issue":"7","key":"pone.0342452.ref042","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/stem.3016","article-title":"Concise Review: Mesenchymal Stem Cells: From Roots to Boost","volume":"37","author":"A Andrzejewska","year":"2019","journal-title":"Stem Cells"},{"issue":"4","key":"pone.0342452.ref043","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5966\/sctm.2015-0161","article-title":"Obesity Determines the Immunophenotypic Profile and Functional Characteristics of Human Mesenchymal Stem Cells From Adipose Tissue","volume":"5","author":"G Pach\u00f3n-Pe\u00f1a","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"pone.0342452.ref044","first-page":"9801358","article-title":"Current Status and Perspectives of Human Mesenchymal Stem Cell Therapy","volume":"2022","author":"JR Choi","year":"2020","journal-title":"Stem Cells International"},{"issue":"7","key":"pone.0342452.ref045","first-page":"861","article-title":"Cell Therapy in the Treatment of Female Stress Urinary Incontinence: Current Status and Future Proposals","volume":"14","author":"C Gonz\u00e1lez Enguita","year":"2024","journal-title":"Life (Basel)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:21:54Z","timestamp":1772216514000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342452"}},"subtitle":[],"editor":[{"given":"Vikash","family":"Chandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0342452","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}